Home/Filings/4/0001562180-24-001980
4//SEC Filing

GROENHUYSEN WILHELMUS CM 4

Accession 0001562180-24-001980

CIK 0001645113other

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 4:28 PM ET

Size

16.6 KB

Accession

0001562180-24-001980

Insider Transaction Report

Form 4
Period: 2024-02-27
GROENHUYSEN WILHELMUS CM
Chief Financial Officer
Transactions
  • Award

    Ordinary Shares

    2023-12-31$12.69/sh+3$38209,828 total
  • Award

    Ordinary Shares

    2024-02-27$16.30/sh+47,034$766,654256,862 total
  • Sale

    Ordinary Shares

    2024-02-28$16.14/sh2,303$37,177254,559 total
  • Award

    Stock Options (Right to buy)

    2024-02-27$16.30/sh+71,920$1,172,29671,920 total
    Exercise: $16.30From: 2025-02-27Exp: 2034-02-26Ordinary Shares (71,920 underlying)
Footnotes (5)
  • [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2023 through December 31, 2023. This transaction is also exempt under Rule 16b-3(c).
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2023.
  • [F3]Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
  • [F4]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  • [F5]Options to buy 71,920 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001264783

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:28 PM ET
Size
16.6 KB